MoneyWorks4Me

Bliss GVS Pharma informs about quarterly statement of investor complaints

21 Jan 2016 Evaluate

Bliss GVS Pharma has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.30
Dr. Reddys Labs. 1172.60
Cipla 1295.10
Lupin 1951.60
Zydus Lifesciences 1111.65
View more..